Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan; AC) therapy yields a better outcome than postoperative AC therapy, if a relationship exists between outcome and tumor response to preoperative chemotherapy, and if such therapy results in the performance of more lumpectomies. PATIENTS AND METHODS: Women (1,523) enrolled onto National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18 were randomly assigned to preoperative or postoperative AC therapy. Clinical tumor response to preoperative therapy was graded as complete (cCR), partial (cPR), or no response (cNR). Tumors with a cCR were further categorized as either pathologic complete response (pCR) or invasive cells (pINV). Disease-free survival (DFS), distant disease-free survival (DDFS), and survival were estimated through 5 years and compared between treatment groups. In the preoperative arm, proportional-hazards models were used to investigate the relationship between outcome and tumor response. RESULTS: There was no significant difference in DFS, DDFS, or survival (P = .99, .70, and .83, respectively) among patients in either group. More patients treated preoperatively than postoperatively underwent lumpectomy and radiation therapy (67.8% v 59.8%, respectively). Rates of ipsilateral breast tumor recurrence (IBTR) after lumpectomy were similar in both groups (7.9% and 5.8%, respectively; P = .23). Outcome was better in women whose tumors showed a pCR than in those with a pINV, cPR, or cNR (relapse-free survival [RFS] rates, 85.7%, 76.9%, 68.1%, and 63.9%, respectively; P < .0001), even when baseline prognostic variables were controlled. When prognostic models were compared for each treatment group, the preoperative model, which included breast tumor response as a variable, discriminated outcome among patients to about the same degree as the postoperative model. CONCLUSION: Preoperative chemotherapy is as effective as postoperative chemotherapy, permits more lumpectomies, is appropriate for the treatment of certain patients with stages I and II disease, and can be used to study breast cancer biology. Tumor response to preoperative chemotherapy correlates with outcome and could be a surrogate for evaluating the effect of chemotherapy on micrometastases; however, knowledge of such a response provided little prognostic information beyond that which resulted from postoperative therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Brown, A., Mamounas, E., Wieand, S., Robidoux, A., Margolese, R. G., Cruz, A. B., Fisher, E. R., Wickerham, D. L., Wolmark, N., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2483 · Cited by 1,801
Self-citationFisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,464
Self-citationDQIS Research Group (2026) · PubMed · doi:10.5281/zenodo.21937949 · Cited by 1,327
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Fisher, B., Dignam, J., Emir, B., Bryant, J., DeCillis, A., Wolmark, N., Wickerham, D. L., Dimitrov, N. V., Abramson, N., Atkins, J. N., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1673 · Cited by 521
Self-citationScholl, S. M., Fourquet, A., Asselain, B., Pierga, J. Y., Vilcoq, J. R., Durand, J. C., Dorval, T., Palangié, T., Jouve, M., Beuzeboc, P., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90537-1 · Cited by 424
Fisher, B., Gündüz, N., & Saffer, E. (1983) · PubMed · Cited by 422
Self-citationEffect of surgical removal on the growth and kinetics of residual tumor.
Gündüz, N., Fisher, B., & Saffer, E. (1979) · PubMed · Cited by 410
Self-citationPresence of a growth-stimulating factor in serum following primary tumor removal in mice.
Fisher, B., Gündüz, N., Coyle, J., Rudock, C., & Saffer, E. (1989) · PubMed · Cited by 361
Self-citationMauriac, L., Durand, M., Avril, A., & Dilhuydy, J.-M. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057953 · Cited by 268
Kinetics of mammary tumor cell growth and implications for therapy
Skipper, H. E. (1971) · Cancer · doi:10.1002/1097-0142(197112)28:6<1479::aid-cncr2820280622>3.0.co;2-m · Cited by 234
Cited by
von Minckwitz, G., Untch, M., Blohmer, J.-U., Costa, S. D., Eidtmann, H., Fasching, P. A., Gerber, B., Eiermann, W., Hilfrich, J., Huober, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8595 · Cited by 2,659
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789
“Preoperative therapy, initially used only for locally advanced breast cancer, has become more common for patients with operable disease.(1-17) This allows more individuals to undergo breast-conserving procedures and provides for observation of response to treatment.”
BackgroundMethodResultInfluentialSelf-citationDenkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Symmans, W. F., Peintinger, F., Hatzis, C., Rajan, R., Kuerer, H., Valero, V., Assad, L., Poniecka, A., Hennessy, B., Green, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6823 · Cited by 1,654
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
European guidelines for quality assurance in breast cancer screening and diagnosis
Amendoeira, I., Perry, N., Broeders, M. J. M., de Wolf, C., Törnberg, S., Holland, R. D., & von Karsa, L. (2013) · Zurich Open Repository and Archive (University of Zurich) · doi:10.2772/13196 · Cited by 1,556
Wolmark, N., Wang, J., Mamounas, E., Bryant, J., & Fisher, B. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003469 · Cited by 1,299
Self-citationNeoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,200
Buzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.032 · Cited by 1,171
Bear, H. D., Anderson, S., Brown, A., Smith, R., Mamounas, E. P., Fisher, B., Margolese, R., Theoret, H., Soran, A., Wickerham, D. L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.005 · Cited by 1,118
Self-citationvan der Hage, J. A., van de Velde, C. J. H., Julien, J.-P., Tubiana-Hulin, M., Vandervelden, C., Duchateau, L., & Cooperating Investigators (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4224 · Cited by 1,107
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Korde, L. A., Somerfield, M. R., Carey, L. A., Crews, J. R., Denduluri, N., Hwang, E. S., Khan, S. A., Loibl, S., Morris, E. A., Perez, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03399 · Cited by 1,040
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Ogston, K. N., Miller, I. D., Payne, S., Hutcheon, A. W., Sarkar, T. K., Smith, I., Schofield, A., & Heys, S. D. (2003) · The Breast · doi:10.1016/s0960-9776(03)00106-1 · Cited by 982
Bear, H. D., Anderson, S., Smith, R. E., Geyer, C. E., Mamounas, E. P., Fisher, B., Brown, A. M., Robidoux, A., Margolese, R., Kahlenberg, M. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1665 · Cited by 943
Self-citationOverview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel
Smith, I. C., Heys, S. D., Hutcheon, A. W., Miller, I. D., Payne, S., Gilbert, F. J., Ah-See, A. K., Eremin, O., Walker, L. G., Sarkar, T. K., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1456 · Cited by 782
Kaufmann, M., Hortobagyi, G. N., Goldhirsch, A., Scholl, S., Makris, A., Valagussa, P., Blohmer, J.-U., Eiermann, W., Jackesz, R., Jonat, W., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6187 · Cited by 725
Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N., Mejia, J. A., Booser, D., Theriault, R. L., Buzdar, A. U., Dempsey, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6861 · Cited by 721
Eiermann, W., Paepke, S., Appfelstaedt, J., Llombart-Cussac, A., Eremin, J., Vinholes, J., Mauriac, L., Ellis, M., Lassus, M., Chaudri-Ross, H. A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013128213451 · Cited by 713
Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity
Li, C. I., Malone, K. E., & Daling, J. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.49 · Cited by 662
Hellmann, M. D., Chaft, J. E., William, W. N., Rusch, V., Pisters, K. M. W., Kalhor, N., Pataer, A., Travis, W. D., Swisher, S. G., & Kris, M. G. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70334-6 · Cited by 646
Gianni, L., Zambetti, M., Clark, K., Baker, J., Cronin, M., Wu, J., Mariani, G., Rodriguez, J., Carcangiu, M., Watson, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0818 · Cited by 626
Guarneri, V., Broglio, K., Kau, S.-W., Cristofanilli, M., Buzdar, A. U., Valero, V., Buchholz, T., Meric, F., Middleton, L., Hortobagyi, G. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6914 · Cited by 601
Mamounas, E. P., Anderson, S. J., Dignam, J. J., Bear, H. D., Julian, T. B., Geyer, C. E., Taghian, A., Wickerham, D. L., & Wolmark, N. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8369 · Cited by 587
Self-citationAyers, M., Symmans, W. F., Stec, J., Damokosh, A. I., Clark, E., Hess, K., Lecocke, M., Metivier, J., Booser, D., Ibrahim, N., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.166 · Cited by 566
Overview of Breast Cancer Therapy
Moo, T.-A., Sanford, R., Dang, C., & Morrow, M. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.006 · Cited by 551
Houssami, N., Macaskill, P., von Minckwitz, G., Marinovich, M. L., & Mamounas, E. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.05.023 · Cited by 548
Self-citationMamounas, E. P., Brown, A., Anderson, S., Smith, R., Julian, T., Miller, B., Bear, H. D., Caldwell, C. B., Walker, A. P., Mikkelson, W. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.188 · Cited by 548
Self-citationVeronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., & Viale, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66546-4 · Cited by 542
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Hylton, N. M., Blume, J. D., Bernreuter, W. K., Pisano, E. D., Rosen, M. A., Morris, E. A., Weatherall, P. T., Lehman, C. D., Newstead, G. M., Polin, S., et al. (2012) · Radiology · doi:10.1148/radiol.12110748 · Cited by 502
Breast Cancer Treatments: Updates and New Challenges
Burguin, A., Diorio, C., & Durocher, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080808 · Cited by 488
Weigelt, B., Baehner, F. L., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2648 · Cited by 482
Treatment of early-stage breast cancer
Hurd, T. C., Edge, S. B., Kahlenberg, M. S., Stomper, P. C., Proulx, G. M., Schwartz, G., Khatri, V., & Winston, J. S. (1999) · Current Problems in Cancer · doi:10.1016/s0147-0272(99)90004-1 · Cited by 477
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Bear, H. D., Tang, G., Rastogi, P., Geyer, C. E., Robidoux, A., Atkins, J. N., Baez-Diaz, L., Brufsky, A. M., Mehta, R. S., Fehrenbacher, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111097 · Cited by 461
Self-citationYau, C., Osdoit, M., van der Noordaa, M., Shad, S., Wei, J., de Croze, D., Hamy, A.-S., Laé, M., Reyal, F., Sonke, G. S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00589-1 · Cited by 456
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 450
Boughey, J. C., McCall, L. M., Ballman, K. V., Mittendorf, E. A., Ahrendt, G. M., Wilke, L. G., Taback, B., Leitch, A. M., Flippo-Morton, T., & Hunt, K. K. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000924 · Cited by 440
Hennessy, B. T., Hortobagyi, G. N., Rouzier, R., Kuerer, H., Sneige, N., Buzdar, A. U., Kau, S. W., Fornage, B., Sahin, A., Broglio, K., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5023 · Cited by 420
Green, M. C., Buzdar, A. U., Smith, T., Ibrahim, N. K., Valero, V., Rosales, M. F., Cristofanilli, M., Booser, D. J., Pusztai, L., Rivera, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.232 · Cited by 419
von Minckwitz, G., Raab, G., Caputo, A., Schütte, M., Hilfrich, J., Blohmer, J. U., Gerber, B., Costa, S. D., Merkle, E., Eidtmann, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.078 · Cited by 417
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
Rouzier, R., Rajan, R., Wagner, P., Hess, K. R., Gold, D. L., Stec, J., Ayers, M., Ross, J. S., Zhang, P., Buchholz, T. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408974102 · Cited by 413
Fisher, E. R., Wang, J., Bryant, J., Fisher, B., Mamounas, E., & Wolmark, N. (2002) · Cancer · doi:10.1002/cncr.10741 · Cited by 413
Self-citationPreoperative chemotherapy for women with operable breast cancer
van der Hage, J. H., van de Velde, C. J., Mieog, S. J., & Charehbili, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005002.pub2 · Cited by 407
Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1676 · Cited by 406
Yeh, E., Slanetz, P., Kopans, D. B., Rafferty, E., Georgian-Smith, D., Moy, L., Halpern, E., Moore, R., Kuter, I., & Taghian, A. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 403
Robidoux, A., Tang, G., Rastogi, P., Geyer, C. E., Azar, C. A., Atkins, J. N., Fehrenbacher, L., Bear, H. D., Baez-Diaz, L., Sarwar, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70411-x · Cited by 386
Self-citationMarinovich, M. L., Houssami, N., Macaskill, P., Sardanelli, F., Irwig, L., Mamounas, E. P., von Minckwitz, G., Brennan, M. E., & Ciatto, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs528 · Cited by 382
Self-citationLohrisch, C., Paltiel, C., Gelmon, K., Speers, C., Taylor, S., Barnett, J., & Olivotto, I. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6089 · Cited by 373
Kuerer, H. M., Sahin, A. A., Hunt, K. K., Newman, L. A., Breslin, T. M., Ames, F. C., Ross, M. I., Buzdar, A. U., Hortobagyi, G. N., & Singletary, S. E. (1999) · Annals of Surgery · doi:10.1097/00000658-199907000-00011 · Cited by 357
Colleoni, M., Viale, G., Zahrieh, D., Pruneri, G., Gentilini, O., Veronesi, P., Gelber, R. D., Curigliano, G., Torrisi, R., Luini, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0380 · Cited by 353
Cataliotti, L., Buzdar, A. U., Noguchi, S., Bines, J., Takatsuka, Y., Petrakova, K., Dube, P., & Tosello de Oliveira, C. (2006) · Cancer · doi:10.1002/cncr.21872 · Cited by 352
Kaufmann, M., von Minckwitz, G., Smith, R., Valero, V., Gianni, L., Eiermann, W., Howell, A., Costa, S. D., Beuzeboc, P., Untch, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.136 · Cited by 351
Dowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A., Griffith, C., Boeddinghaus, I., Salter, J., Detre, S., Hills, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.951s.11.2 · Cited by 348
Semiglazov, V. F., Semiglazov, V. V., Dashyan, G. A., Ziltsova, E. K., Ivanov, V. G., Bozhok, A. A., Melnikova, O. A., Paltuev, R. M., Kletzel, A., & Berstein, L. M. (2007) · Cancer · doi:10.1002/cncr.22789 · Cited by 333
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma
Morrow, M., Strom, E. A., Bassett, L. W., Dershaw, D. D., Fowble, B., Giuliano, A., Harris, J. R., O'Malley, F., Schnitt, S. J., Singletary, S. E., et al. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.5.277 · Cited by 324
Rouzier, R., Extra, J.-M., Klijanienko, J., Falcou, M.-C., Asselain, B. J. R., Vincent‐Salomon, A., Vielh, P. R., & Bourstyn, E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1304 · Cited by 315
Yankeelov, T. E., Lepage, M., Chakravarthy, A., Broome, E. E., Niermann, K. J., Kelley, M. C., Meszoely, I., Mayer, I. A., Herman, C. R., McManus, K., et al. (2007) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2006.09.006 · Cited by 314
Positron Emission Tomography (PET) in Oncology
Gallamini, A., Zwarthoed, C., & Borra, A. (2014) · Cancers · doi:10.3390/cancers6041821 · Cited by 312
Ono, M., Tsuda, H., Shimizu, C., Yamamoto, S., Shibata, T., Yamamoto, H., Hirata, T., Yonemori, K., Ando, M., Tamura, K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1554-7 · Cited by 308
Cardoso, F., Loibl, S., Pagani, O., Graziottin, A., Panizza, P., Martincich, L., Gentilini, O., Peccatori, F., Fourquet, A., Delaloge, S., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.004 · Cited by 304
Mazouni, C., Peintinger, F., Wan-Kau, S., Andre, F., Gonzalez-Angulo, A. M., Symmans, W. F., Meric-Bernstam, F., Valero, V., Hortobagyi, G. N., & Pusztai, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2271 · Cited by 299
Chang, J. H., Vines, E., Bertsch, H., Fraker, D. L., Czerniecki, B. J., Rosato, E. F., Lawton, T., Conant, E. F., Orel, S. G., Schuchter, L., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1231::aid-cncr1123>3.0.co;2-k · Cited by 297
Choe, R., Corlu, A., Lee, K., Durduran, T., Konecky, S. D., Grosicka‐Koptyra, M., Arridge, S. R., Czerniecki, B. J., Fraker, D. L., DeMichele, A., et al. (2005) · Medical Physics · doi:10.1118/1.1869612 · Cited by 295
Rouzier, R., Pusztai, L., Delaloge, S., Gonzalez-Angulo, A. M., Andre, F., Hess, K. R., Buzdar, A. U., Garbay, J.-R., Spielmann, M., Mathieu, M.-C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.2898 · Cited by 286
Park, S. H., Moon, W. K., Cho, N., Song, I. C., Chang, J. M., Park, I.-A., Han, W., & Noh, D.-Y. (2010) · Radiology · doi:10.1148/radiol.10092021 · Cited by 281
Fuster, D., Duch, J., Paredes, P., Velasco, M., Muñoz, M., Santamaría, G., Fontanillas, M., & Pons, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1496 · Cited by 280
Burstein, H. J., Harris, L. N., Gelman, R., Lester, S. C., Nunes, R. A., Kaelin, C. M., Parker, L. M., Ellisen, L. W., Kuter, I., Gadd, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.124 · Cited by 280
Partridge, S. C., Gibbs, J. E., Lu, Y., Esserman, L. J., Tripathy, D., Wolverton, D. S., Rugo, H. S., Hwang, E. S., Ewing, C. A., & Hylton, N. M. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.6.01841774 · Cited by 278
Past, Present, and Future Challenges in Breast Cancer Treatment
Sledge, G. W., Mamounas, E. P., Hortobagyi, G. N., Burstein, H. J., Goodwin, P. J., & Wolff, A. C. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.4139 · Cited by 277
Self-citationAlmendro, V., Cheng, Y.-K., Randles, A., Itzkovitz, S., Marusyk, A., Ametller, E., Gonzalez-Farre, X., Muñoz, M., Russnes, H. G., Helland, Å., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.041 · Cited by 274
Performance of FDG PET/CT in the Clinical Management of Breast Cancer
Groheux, D., Espié, M., Giacchetti, S., & Hindié, E. (2013) · Radiology · doi:10.1148/radiol.12110853 · Cited by 271
Diffuse optical imaging using spatially and temporally modulated light
O’Sullivan, T. D., Cerussi, A. E., Cuccia, D. J., & Tromberg, B. J. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.7.071311 · Cited by 270
Kong, X., Moran, M. S., Zhang, N., Haffty, B., & Yang, Q. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.014 · Cited by 265
Ring, A. E., Smith, I. E., Ashley, S., Fulford, L. G., & Lakhani, S. R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602235 · Cited by 262
Stearns, V., Ewing, C. A., Slack, R., Penannen, M. F., Hayes, D. F., & Tsangaris, T. N. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573060 · Cited by 260
Chollet, P., Amat, S., Cure, H., de Latour, M., Le Bouedec, G., Mouret-Reynier, M.-A., Ferriere, J.-P., Achard, J.-L., Dauplat, J., & Penault-Llorca, F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600210 · Cited by 259
Tolaney, S. M., Boucher, Y., Duda, D. G., Martin, J. D., Seano, G., Ancukiewicz, M., Barry, W. T., Goel, S., Lahdenrata, J., Isakoff, S. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518808112 · Cited by 258
“Breast Cancer Res Treat 125(3):687–696.”
BackgroundMcGuire, S. E., Gonzalez-Angulo, A. M., Huang, E. H., Tucker, S. L., Kau, S.-W. C., Yu, T.-K., Strom, E. A., Oh, J. L., Woodward, W. A., Tereffe, W., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.023 · Cited by 257
Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
Cortazar, P., & Geyer, C. E. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4404-8 · Cited by 252
Keam, B., Im, S.-A., Lee, K.-H., Han, S.-W., Oh, D.-Y., Kim, J. H., Lee, S.-H., Han, W., Kim, D.-W., Kim, T.-Y., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2834 · Cited by 235
“It is well confirmed that pCR to neoadjuvant chemotherapy is an independent prognostic factor for survival [28-30].”
BackgroundEffect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Araujo, J. M., Gomez, A. C., Aguilar, A., Salgado, R., Balko, J. M., Bravo, L., Doimi, F., Bretel, D., Morante, Z., Flores, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23099-7 · Cited by 108
Metadata
- Authors
- Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., Margolese, R. G., Cruz, A. B., Hoehn, J. L., Lees, A. W., Dimitrov, N. V., & Bear, H. D.
- Venue
- Journal of Clinical Oncology
- Published
- 1998-08
- Volume
- 16
- Issue
- 8
- Pages
- 2672-2685
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2139510434
- Cited by
- 2,165
- References
- 16
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.